WO2024218609 - COMPOSITION AND METHOD FOR INDUCING LUTEOLYSIS
National phase entry is expected:
Publication Number
WO/2024/218609
Publication Date
24.10.2024
International Application No.
PCT/IB2024/053454
International Filing Date
09.04.2024
Title **
[English]
COMPOSITION AND METHOD FOR INDUCING LUTEOLYSIS
[French]
COMPOSITION ET MÉTHODE D'INDUCTION DE LA LUTÉOLYSE
Applicants **
WELFARE CONCEPTS LIMITED
301r Botany Road, Golflands,
Auckland, 2013, NZ
Inventors
TUCKER, Ian George
301r Botany Road, Golflands
Auckland, 2013, NZ
BHUSAL, Prabhat
301r Botany Road, Golflands
Auckland, 2013, NZ
WALKER, Greg
301r Botany Road, Golflands
Auckland, 2013, NZ
MCDOUGALL, Scott
301r Botany Road, Golflands
Auckland, 2013, NZ
EMSLIE, Forbes Richard
301r Botany Road, Golflands
Auckland, 2013, NZ
Priority Data
2023901142
18.04.2023
AU
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
IP Australia
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 2064 | |
| EPO | Filing, Examination | 16959 | |
| Japan | Filing | 530 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 10035 |
Total: 30163 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
An injectable sustained release composition comprising a prostaglandin, formulated to release the prostaglandin in a sustained manner, and a method of inducing luteolysis of a functional corpus luteum in an animal by the sustained administration of a prostaglandin such as PGF2α, preferably cloprostenol.[French]
L'invention concerne une composition injectable à libération prolongée comprenant une prostaglandine, formulée pour libérer la prostaglandine de manière prolongée, et une méthode d'induction de la lutéolyse d'un corps luteum fonctionnel chez un animal par l'administration prolongée d'une prostaglandine telle que PGF2α, de préférence la cloprosténol.